NYMOX PHARMACEUTICAL CORP reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Quebec Canada, Quebec, Canada
SEC filing record 1 source field available
Fiscal year end
31 December
NYMOX PHARMACEUTICAL CORP has filed 408 SEC EDGAR filings since 08 Aug 1996

SEC filing history

Showing 1-25 of 301 matching filings.

Per page
25
Current page
1
20-F/A File 001-12033

FORM 20-F/A

Filing date
29 Sep 2026
Reporting date
31 Dec 2025
Next action
Verify source filing
20-F/A File 001-12033

FORM 20-F/A

Filing date
16 Sep 2026
Reporting date
31 Dec 2025
Next action
Verify source filing
20-F File 001-12033

FORM 20-F

Filing date
14 Sep 2026
Reporting date
31 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-12033

FORM 6-K

Filing date
31 Aug 2026
Reporting date
31 Aug 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-12033

FORM 6-K

Filing date
07 Aug 2026
Reporting date
07 Aug 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-12033

FORM 6-K

Filing date
03 Jun 2026
Reporting date
02 Jun 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-12033

FORM 6-K

Filing date
27 Mar 2026
Reporting date
27 Mar 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-12033

FORM 6-K

Filing date
07 Nov 2025
Reporting date
07 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-12033

FORM 6-K

Filing date
22 Oct 2025
Reporting date
22 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-12033

FORM 6-K

Filing date
22 Oct 2025
Reporting date
22 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-12033

FORM 6-K

Filing date
23 Sep 2025
Reporting date
23 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-12033

FORM 6-K

Filing date
22 May 2025
Reporting date
22 May 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 20-F File 001-12033

FORM 20-F

Filing date
01 May 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-12033

FORM 6-K

Filing date
11 Mar 2025
Reporting date
11 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-12033

FORM 6-K

Filing date
17 Dec 2024
Reporting date
17 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-12033

FORM 6-K

Filing date
18 Jul 2024
Reporting date
18 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-12033

FORM 6-K

Filing date
16 Jul 2024
Reporting date
17 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-12033

FORM 6-K

Filing date
13 May 2024
Reporting date
13 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-12033

FORM 6-K

Filing date
28 Mar 2024
Reporting date
28 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-12033

FORM 6-K

Filing date
09 Nov 2023
Reporting date
09 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-12033

FORM 6-K

Filing date
06 Nov 2023
Reporting date
03 Nov 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .